Fixed Price IPO | ₹9 Cr | Listed at NSE SME | Fri, Feb 9, 2018 - Wed, Feb 14, 2018
Arvee Laboratories IPO is a fixed price issue of ₹8.91 crores. The issue is entirely a fresh issue of 0.15 crore shares of ₹8.91 crore.
Arvee Laboratories IPO bidding started from Feb 9, 2018 and ended on Feb 14, 2018. The shares got listed on NSE SME on Feb 22, 2018.
Arvee Laboratories IPO price is ₹61 per share. The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹1,22,000 (2000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (4,000 shares), amounting to ₹2,44,000.
Sarthi Capital Advisors Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Wealth First Portfolio Managers Pvt.Ltd..
Refer to Arvee Laboratories IPO RHP for detailed Information.
IPO Open
Fri, Feb 9, 2018
IPO Close
Wed, Feb 14, 2018
Issue Price
₹61 per share
Market Cap (Pre-IPO)
₹33.61 Cr
| IPO Date | 9 to 14 Feb, 2018 |
| Listed on | Thu, Feb 22, 2018 |
| Face Value | ₹10 per share |
| Issue Price | ₹61 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Total Issue Size | 14,60,000 shares (agg. up to ₹9 Cr) |
| Reserved for Market Maker | 76,000 shares Wealth First Portfolio Managers Pvt.Ltd. (agg. up to ₹0.4636 Cr) |
| Fresh Issue (Ex Market Maker) | 13,84,000 shares (agg. up to ₹8 Cr) |
| Net Offered to Public | 13,84,000 shares (agg. up to ₹8 Cr) |
| Share Holding Pre Issue | 40,50,000 shares |
| Share Holding Post Issue | 55,10,000 shares |
| NSE Symbol | ARVEE |
| ISIN | INE006Z01016 |
Arvee Laboratories IPO comprises a total issue size of 14,60,000 shares. The net offer to the public is 13,84,000 shares, after excluding 76,000 shares allotted on a firm basis. Of the Net offer 6,92,000 (50.00%) allocated to NII 6,92,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 6,92,000 | 50.00% | 47.40% |
| Retail Shares Offered | 6,92,000 | 50.00% | 47.40% |
| Firm Reservations | |||
| Market Maker Shares Offered | 76,000 | 5.21% | |
| Total Shares Offered | 14,60,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 2,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,22,000 |
| Retail (Max) | 1 | 2,000 | ₹1,22,000 |
| HNI (Min) | 2 | 4,000 | ₹2,44,000 |
Incorporated in 2012, Arvee Laboratories (India) Limited is Ahmadabad, Gujarat based company engaged in trading in specialty chemicals by getting manufacturing done on job work basis. Company has plans to begin manufacturing of specialty chemicals in near future.
Arvee Labs is mainly engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. Company caters to the demand of both domestic as well as international markets.
Arvee Labs bought land, building and machineries from Skylink Chemicals Private Limited who was engaged in manufacturing of specialty chemicals. Currently, Company is negotiating with IDBI Bank Limited to take over the business of Skylead Chemicals Limited which has been declared as sick by BIFR.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Re-payment of Unsecured Loans of Promoters | 8.41 |
| 2 | Issue Expenses | 0.50 |
The Arvee Labs IPO is subscribed 2.9 times on February 14, 2018 5:00:00 PM (Day 3). The public issue subscribed 3.62 times in the retail category, [.] times in the QIB category, and 2.18 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | 2.18 | 6,92,000 | 15,08,000 |
| Retail | 3.62 | 6,92,000 | 25,02,000 |
| Total | 2.9 | 13,84,000 | 40,10,000 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Payment to Merchant Banker including expenses towards printing, advertising, and payment to other intermediaries such as Registrars, Market Makers, Bankers etc. | 0.42 |
| 2 | Regulatory Fees & Other Expenses | 0.08 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹61.00 |
| Open | ₹60.95 |
| Low | ₹60.50 |
| High | ₹66.50 |
| Last Trade | ₹62.50 |
Lead Manager Reports
Arvee Laboratories IPO is a SME IPO of 14,60,000 equity shares of the face value of ₹10 aggregating up to ₹9 Crores. The issue is priced at ₹61 per share. The minimum order quantity is 2000.
The IPO opens on Fri, Feb 9, 2018, and closes on Wed, Feb 14, 2018.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Arvee Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Arvee Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Arvee Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Arvee Laboratories IPO opens on Fri, Feb 9, 2018 and closes on Wed, Feb 14, 2018.
Arvee Laboratories IPO lot size is 2000, and the minimum amount required for application is ₹1,22,000.
You can apply in Arvee Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Arvee Laboratories IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Arvee Laboratories IPO allotment status.
The Arvee Laboratories IPO listing date is on Thu, Feb 22, 2018.
